Controlled-Release of Leuprolide Acetate from Polylactic Acid or Copoly(Lactic/Glycolic) Acid Microcapsules : Influence of Molecular Weight and Copolymer Ratio of Polymer
スポンサーリンク
概要
- 論文の詳細を見る
Polylactic acid (PLA) or copoly(lactic/glycolic) acid (PLGA) microcapsules containing leuprolide acetate were prepared by an in-water drying process and the release patterns were examined in vitro. The release rates were extremely small from microcapsules prepared with PLA of average molecular weight 22500,and from microcapsules prepared with PLGA having average molecular weight 21200 and a copolymer ratio of 75/25 (molar ratio of lactic acid to glycolic acid). The release rate of leuprolide acetate from the microcapsules prepared with PLA of average molecular weight 6000 was relatively fast, but was still too slow to give the desired drug level over one month. Several water-soluble compounds were incorporated into microcapsules prepared with PLA of average molecular weight 22500,in an attempt to increase the release rate by the creation of aqueous channels. These compounds only induced a high initial release and failed to increase drug release. The release profile of the drug from microcapsules prepared with PLGA of average molecular weight 14000 and a copolymer ratio of 75/25 was ideal for one month's release. A small initial release was observed followed by a steady release which lasted for 35d, and approximately followed zero-order kinetics.
- 社団法人日本薬学会の論文
- 1988-04-25
著者
-
島本 次雄
Pharmaceutics Research Laboratories Research And Development Division Takeda Chemical Industries Ltd
-
岡田 弘晃
武田薬品工業株式会社 製剤研究所
-
小川 泰亮
武田薬品工業株式会社 DDS研究所
-
岡田 弘晃
武田薬品工業
-
小川 泰亮
Pharmaceutics Research Laboratories, Research and Development Division, Takeda Chemical Industries,
-
岡田 弘晃
Pharmaceutical Development Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
山本 眞樹
Pharmaceutical Development Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
高田 重行
Pharmaceutical Development Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
小川 泰亮
武田薬品工業(株)dds研究所
-
小川 泰亮
武田薬品工業株式会社dds研究所
-
高田 重行
Pharmaceutical Development Laboratories Central Research Division Takeda Chemical Industries Ltd.
-
山本 眞樹
武田薬品工業 研究開発本部 製剤研究所
-
山本 真樹
武田薬品工業(株)
関連論文
- 徐放性マイクロカプセル製剤からの薬物放出性解析
- LHRH アゴニスト注射用マイクロカプセル徐放剤からの薬物放出in vitro評価系
- Influence of Tablet Dimensions on the Disintegration Time
- AN ASSESSMENT OF GASTROINTESTINAL MUCOSAL DAMAGE IN VIVO : ENHANCEMENT OF URINARY RECOVERY AFTER ORAL ADMINISTRATION OF PHENOLSULFONPHTHALEIN IN ULCER RATS
- Gastro-Intestinal Absorption of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate from Different Dosage Forms in Rats and Dogs
- A New Technique to Efficiently Entrap Leuprolide Acetate into Microcapsules of Polylactic Acid or Copoly(Lactic/Glycolic) Acid
- Stability of Packaged Solid Dosage Forms. VI. Shelf-life Prediction of Packaged Prednisolone Tablets in Relation to Dissolution Properties
- Stability of Packaged Solid Dosage Forms. V. Prediction of the Effect of Aging on the Disintegration of Packaged Tablets influenced by Moisture and Heat
- Stability of Packaged Solid Dosage Forms. III. Kinetic Studies by Differential Analysis on the Deterioration of Sugar-coated Tablets under the Influence of Moisture and Heat
- Stability of Packaged Solid Dosage Forms. II. Shelf-life Prediction for Packaged Sugar-coated Tablets Liable to Moisture and Heat Damage
- Stability of Packaged Solid Dosage Forms. I. Shelf-life Prediction for Packaged Tablets Liable to Moisture Damage
- Assessment of Pharmaceutical Excipient-Induced Gastrointestinal Mucosal Damage in Rats in Vivo by Measuring the Permeation of Phenolsulfonphthalein
- Enhancement of the Anti-tumor Activity of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with an F (ab')_2 Fragment of Murine Monoclonal Antibody against rIL-2
- Pharmacokinetic Alteration in Rats of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with a Monoclonal Antibody against rIL-2
- 酢酸リュープロレリン徐放性注射剤
- Effects of Physiological Factors on the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in an Emulsion in Rats
- Effects of the Physicochemical Properties of the Emulsion Formulation of the Bioavailability of Ethyl 2-Chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in Rats
- ポリ乳酸/グリコール酸を用いた甲状腺刺激ホルモン放出ホルモン徐放性マイクロスフェア
- In Vivo Release Profiles of Leuprolide Acetate from Microcapsules Prepared with Polylactic Acids or Copoly(Lactic/Glycolic) Acids and in Vivo Degradation of These Polymers
- Controlled-Release of Leuprolide Acetate from Polylactic Acid or Copoly(Lactic/Glycolic) Acid Microcapsules : Influence of Molecular Weight and Copolymer Ratio of Polymer
- An ex Vivo Assay for Estimating the Antiviral State of Hepatocytes
- 生体内分解性高分子を用いた黄体形成ホルモン放出ホルモン誘導体の放出制御に関する研究
- 生体内分解性高分子を利用した水溶性ペプチドのマイクロカプセル形放出制御製剤
- Interaction of Methyl p-Hydroxybenzoate with Polyoxyethylene Dodecyl Ethers
- Ultrafiltration Method for Measuring Free Preservatives in Aqueous Phase of Oil-in-Water Emulsions
- ホルモン依存性疾患に有用な治療剤:リュ-プリン 長期徐放マイクロカプセルの設計
- 消化管粘膜付着性細粒剤の有効性評価におけるヒトと実験動物との比較
- 1ヵ月にわたり薬物を徐放するマイクロカプセル,リュープリン【○!R】の開発
- 黄体形成ホルモン放出ホルモンアゴニストのDDS
- 第1回DDS研究会
- 安定性研究のための人工気象室
- GnRHアゴニスト--酢酸リュ-プロレリン徐放性注射剤の効果
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の水溶液中でのマルトシル-β-シクロデキストリンによる安定化
- アスコルビン酸誘導体, disodium 2-O-octadecyl-5, 6-di-O-sulfoascorbate (CV-11464) の安定性およびその分解機構
- A Model for the Evaluation and Prediction of Preservative Activity in Oil-in-Water Emulsions
- Effect of Polyols on the Interaction of p-Hydroxybenzoic Acid Esters with Polyoxyethylene Dodecyl Ether
- Interaction of p-Hydroxybenzoic Acid Esters with Polyethylene Glycol
- Interaction of Propyl p-Hydroxybenzoate with Polyoxyethylene Dodecyl Ethers
- Flocculation and Deflocculation of Veegum Suspensions by Polyoxyethylene Hydrogenated Castor Oil
- Theoretical Consideration on Dosage Variation
- 湿潤粉体の臼内圧力伝達率と練合特性について
- ルプロンデポの開発 : DDSは第2の創薬